May 7
|
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
|
May 7
|
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
|
May 7
|
Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip
|
May 7
|
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
|
May 7
|
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
|
May 6
|
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
|
May 6
|
Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
|
May 4
|
Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
|
Apr 30
|
Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
|
Apr 25
|
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
|
Apr 23
|
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
|
Apr 15
|
Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
|
Apr 11
|
The WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control
|
Apr 9
|
Opill and WNBA Team Up for Groundbreaking Partnership
|
Apr 4
|
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
|
Mar 28
|
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
|
Mar 18
|
Prepare for Takeoff With Perrigo
|
Mar 5
|
Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript
|
Mar 4
|
First over-the-counter birth control pill in US begins shipping to stores
|
Mar 4
|
Over-the-Counter Birth Control Pill to Be Available Within Weeks on Retail Shelves
|